-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QSWHg1Vj4TRe2QW+lPWyO051P+CGruKWlJUO89qY/3BACwt5U3rDdj81cq+zwYDN yi00LdKGavhc3TQbtcfGEg== 0000878088-08-000060.txt : 20081120 0000878088-08-000060.hdr.sgml : 20081120 20081120184500 ACCESSION NUMBER: 0000878088-08-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081118 FILED AS OF DATE: 20081120 DATE AS OF CHANGE: 20081120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MacPhee John A CENTRAL INDEX KEY: 0001339976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 081205030 BUSINESS ADDRESS: BUSINESS PHONE: (201) 802-4000 MAIL ADDRESS: STREET 1: C/O PAR PHARMACEUTICAL COMPANIES, INC. STREET 2: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2008-11-18 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001339976 MacPhee John A C/O PAR PHARMACEUTICAL COMPANIES, INC. 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 0 1 0 0 EVP, President, Strativa Pharm Common Stock 2008-11-18 4 A 0 45496 0 A 158239 D Common Stock, Option to Buy 10.99 2008-11-18 4 A 0 102881 0 A 2018-11-18 Common Stock 102881 102881 D Awards of Executive Retention Restricted Shares and Executive Retention Stock Option under the Company's 2004 Performance Equity Plan. 100% of the Restricted Shares and Stock Option vest on the third anniversary of the date of grant contingent upon Mr. MacPhee being continuously employed by the Company; however, 66-2/3% of the Restricted Stock and Stock Option vest upon satisfaction of the following conditions: (i) Mr. MacPhee is continuously employed with the Company through the second anniversary of the date of grant and (ii) the closing price of the Company's common stock as reported by The New York Stock Exchange, Inc. ("NYSE") exceeds 120% of the closing price on the grant date, for at least 20 days during the quarter ending December 31, 2010. The closing price of the Company's common stock as reported by the NYSE on the date of grant was $10.99. Includes (i) 32,980 shares of Common Stock, and (ii) 125,259 shares of Restricted Stock and Restricted Stock Units, held by Mr. MacPhee. /s/ Marian E. Gustafson for John MacPhee 2008-11-20 -----END PRIVACY-ENHANCED MESSAGE-----